Articles Referencing FOLD
After-Hours Earnings Report for March 12, 2013 : KW, DOLE, ACAD, GCA, GNMK, AVID, WSR, KTOS, GERN, ACRX, FOLD, GCAP
3/12/2013, 2:00 pm from NASDAQ.com News in News Headlines, Earnings
The following companies are expected to report earnings after
hours on 03/12/2013. Visit our Earnings
Calendar for a full list of expected earnings releases. Kennedy-Wilson Holdings Inc. ( ... Read >>
Glaxo's Influenza Vaccine Approved - Analyst Blog
12/24/2012, 3:00 pm from Zacks.com in Investing, Business, Stocks
GlaxoSmithKline ( GSK )
recently announced that it has received US Food and Drug
Administration (FDA) approval for its influenza vaccine, Fluarix
Quadrivalent for the prevention of... Read >>
Glaxo/Amicus' Fabry Drug Disappoints - Analyst Blog
12/21/2012, 12:14 pm from Zacks.com in Investing, Business, Stocks
GlaxoSmithKline ( GSK )
and partner Amicus Therapeutics ( FOLD )
recently presented disappointing top-line six-month primary
treatment period data from the first phase III global... Read >>
Pre-Market Most Active for Dec 20, 2012 : NOK, MDRX, QQQ, BAC, VVUS, ARRS, SD, NJ, PHG, TOT, FOLD, ILMN
12/20/2012, 8:39 am from NASDAQ.com News in News Headlines, Pre-market Most Active
The NASDAQ 100
Pre-Market Indicator is up 1.47 to 2,692.46. The total
Pre-Market volume is currently 7,742,642 shares traded.
The following are the
most active stocks for the pre-market... Read >>
Stocks Set to Jump as Greece Approves Austerity Measures
2/13/2012, 8:25 am from Schaeffer's Investment Research in Investing, Options
After a
turbulent week
based mostly on the ongoing debt drama emanating from across the
pond, stock futures are headed higher this morning, as Greece
appears to have reached a fiscal... Read >>
Developments for Parkinson's Disease Ignite Investor Enthusiasm
11/16/2009, 3:23 am from SeekingAlpha in Investing, Technology, Stocks
Michael
Becker
submits:
In our August 2009 article titled "
Treating Parkinson's Disease: Investment
Opportunities and Challenges
," we reviewed some of the historical... Read >>